![Thomas B. Okarma](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas B. Okarma
Direttore Tecnico/Scientifico/R&S presso Rejuvenan Global Health, Inc.
Posizioni attive di Thomas B. Okarma
Società | Posizione | Inizio | Fine |
---|---|---|---|
Geron Bio-Med Ltd. | Direttore/Membro del Consiglio | - | - |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direttore/Membro del Consiglio | - | - |
Rejuvenan Global Health, Inc.
![]() Rejuvenan Global Health, Inc. Medical/Nursing ServicesHealth Services Rejuvenan Global Health, Inc. engages in the provision of wellness programs and telemedicine consultations. It offers personalized coaching and other interactive tools that drive behavioral change through the adoption of healthy lifestyle. The company was founded by Fred Nazem and Rishi Madhok and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Thomas B. Okarma
Precedenti posizioni note di Thomas B. Okarma
Società | Posizione | Inizio | Fine |
---|---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Direttore/Membro del Consiglio | 01/09/2012 | 10/04/2014 |
Amministratore Delegato | 01/09/2012 | 10/04/2014 | |
Presidente | 01/09/2012 | 10/04/2014 | |
GERON CORPORATION | Direttore/Membro del Consiglio | 01/05/1998 | 08/02/2011 |
Presidente | 01/05/1998 | 08/02/2011 | |
Cell Therapies Pty Ltd. | Corporate Officer/Principal | 01/05/1998 | 01/05/1998 |
Rhone-Poulenc Rorer, Inc.
![]() Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Corporate Officer/Principal | 01/12/1996 | 01/12/1996 |
Applied Immune Sciences, Inc.
![]() Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Fondatore | 01/01/1995 | 01/01/1995 |
Presidente | - | 01/01/1995 |
Formazione di Thomas B. Okarma
Dartmouth College | Undergraduate Degree |
Stanford University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Regno Unito | 2 |
Australia | 2 |
Posizioni
Director/Board Member | 5 |
President | 3 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
GERON CORPORATION | Health Technology |
Aziende private | 7 |
---|---|
Applied Immune Sciences, Inc.
![]() Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Health Technology |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Asterias Biotherapeutics, Inc.
![]() Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Rejuvenan Global Health, Inc.
![]() Rejuvenan Global Health, Inc. Medical/Nursing ServicesHealth Services Rejuvenan Global Health, Inc. engages in the provision of wellness programs and telemedicine consultations. It offers personalized coaching and other interactive tools that drive behavioral change through the adoption of healthy lifestyle. The company was founded by Fred Nazem and Rishi Madhok and is headquartered in New York, NY. | Health Services |
Rhone-Poulenc Rorer, Inc.
![]() Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Geron Bio-Med Ltd. | |
Cell Therapies Pty Ltd. |
- Borsa valori
- Insiders
- Thomas B. Okarma
- Esperienza